Podcast: Play in new window | Download (Duration: 58:10 — 38.5MB)
Subscribe: RSS
Jon Marinaro interviews Dr. Eric Nadler along with Dr. Gary Schwartz our guest for the second episode in a row
Key Takeaways
- Cancer is increasingly becoming a chronic, manageable disease.
- ECMO may be appropriate in carefully selected oncology patients.
- Close collaboration between oncologists and ECMO teams is essential.
- Modern cancer therapies can work rapidly enough that ECMO may meaningfully change outcomes.
- Awareness and education gaps exist on both sides:
- intensivists may underestimate modern oncology,
- oncologists may underestimate ECMO capabilities.
Eric Nadler, M.D., MPP, is board certified in medical oncology. He serves as a medical director of US Oncology Health Outcomes. He remains active in US Oncology Network and Texas Oncology research committees in lung cancer, head and neck cancer, and sarcoma. Dr. Nadler’s passions are oncology research and oncology education.
Any additional info about the potential ACEP ecmo course mentioned at beginning of the episode?